Search results
Jul 14, 2016 · The last American Thoracic Society (ATS)/Infectious Diseases Society of America (IDSA) HAP/VAP guidelines, published in 2005 [1], provided evidence-based recommendations for the prevention, diagnosis, and treatment of HCAP, HAP, and VAP.
Jul 19, 2017 · This article focuses on the updated guidelines and reviews the current terminology, etiology, and antimicrobial treatment choices for HAP and VAP. Diagnosis. The guidelines recommend obtaining cultures of respiratory secretions and blood cultures from all patients with suspected HAP or VAP in order to guide antimicrobial treatment.
Hospital-Acquired and Ventilator-Associated Pneumonia (HAP/VAP) Collecting a MRSA nares culture/PCR is recommended for all patients initiating anti-MRSA therapy (e.g. vancomycin) for suspected HAP or VAP. • How to interpret a negative MRSA nares result in patient with possible HAP/VAP
Jun 19, 2024 · The treatment of non-ventilator-associated HAP (nvHAP) and ventilator-associated pneumonia (VAP) will be reviewed here. The diagnosis, epidemiology, pathogenesis, microbiology, risk factors, and prevention of nvHAP and VAP are discussed separately.
Two recent major guidelines on diagnosis and treatment of ventilator-associated pneumonia (VAP) recommend consideration of local antibiotic resistance patterns and individual patient risks for resistant pathogens when formulating an initial empiric antibiotic regimen.
Oct 25, 2023 · Ventilator-associated pneumonia is the most frequent presentation of hospital-acquired infection of the lower respiratory tract, the leading nosocomial infection worldwide.
Last Revised Date: 11/20/2023 Hospital-Acquired Pneumonia for Adults All suggested dosing regimens assume normal renal function; renal dose adjustments may be required.
